Economic Development Funding for Pharmetric Laboratory, LLC
October 21, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This agreement commits up to $1,645,000 in public funds to a private company for facility renovations, impacting the local economic development budget and industrial infrastructure.
Potentially affected actors named in the source documents. Mention is not a position.
Pharmetric Laboratory, LLC
The company receives up to $1,645,000 in funding to renovate their facility.
Local Taxpayers
Public funds are being allocated to a private entity for industrial development.
Last recorded activity October 21, 2025.
Next step not available in the current record.
Summary
Key Facts
- The government approved a funding agreement not to exceed $1,645,000.00.
- The recipient is Pharmetric Laboratory, LLC.
- The funding is allocated through the Employment Sites Program.
- The project involves renovating a 35,080-square-foot former pharmaceutical building.
- The renovated space will function as a sterile manufacturing facility.
- The item is classified as a Delegated Item under the Economic Development body.
- The file identifier for this action is 25-0741D.
- The item was introduced on August 26, 2025.
Frequently Asked Questions
What is the purpose of the $1,645,000 funding?
What program is providing this funding?
Why It Matters
This agreement commits up to $1,645,000 in public funds to a private company for facility renovations, impacting the local economic development budget and industrial infrastructure.
News Coverage
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Industrial Revitalization Focus
The project specifically targets the conversion of an existing pharmaceutical building, suggesting a policy preference for repurposing industrial sites over new construction.
Connected Entities
Sources
webapi.legistar.com
Analysis Score
0–100- Significance45How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools